When combined with gallium, the glasses could kill cancer cells. Lab tests have found that bioactive glasses doped with the ...

With alternative therapies urgently needed, a research team at Aston University has developed a gallium-doped bioactive glass that selectively kills over 99% of bone cancer cells. The main objective ...

Candel Therapeutics CADL, a clinical-stage oncology company, is focused on developing two novel therapeutics, CAN-2409 and ...

Gallium nitride (GaN) semiconductors can now be grown without ammonia, a toxic chemical that needs a sophisticated detoxifying system before it can be released into the atmosphere. The new ...

Among the highlights? Three new Diptyque holiday candles, as well as the brand's buzzy basil-scented candle that wafts away unpleasant odors at home. Baobab Collection's latest advent calendar ...

Every item on this page was chosen by a Town & Country editor. We may earn commission on some of the items you choose to buy. When you walk into my home, there is one thing that is almost always ...

Candlesticks are so named because the rectangular shape and lines on either end resemble a candle with wicks. Each candlestick usually represents one day’s worth of price data about a stock.

There’s some debate about whether burning candles is bad for your health. Some people claim that candles release potentially harmful toxins. Long before the invention of the light bulb ...

A Belgian-Canadian research team claims to have found a way to develop gallium arsenide (GaAs) solar cells at a lower cost while maintaining high power conversion efficiencies. The scientists said ...

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110.

The considerable ownership by individual investors in Candel Therapeutics indicates that they collectively have a greater say in management and business strategy A total of 24 investors have a ...

NEEDHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal ...